You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 2401 to 2425 of about 5880
Next 25
11/01/2012
FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
10/29/2012
Anti-Alcoholism Drug Helps Fight Deadly Brain Tumor
10/28/2012
Landmark Medicare settlement could change lives
10/22/2012
Los Angeles Goes Grey on November 4, 2012
10/11/2012
IBTA E NEWS OCTOBER 2012
UC Irvine opens clinical trial of novel treatment for brain cancer
10/10/2012
Bevacizumab (Avastin) continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.
Effects of Zeng Sheng Ping/ACAPHA on malignant brain tumor growth and Notch signaling.
Impact of extent of resection for recurrent glioblastoma on overall survival.
The addition of temozolomide does not change the pattern of progression of glioblastoma multiforme post-radiotherapy.
10/07/2012
Life`s Mountains: What a Brain Tumor Survivor Learned Climbing a Mountain and Battling "Terminal" Cancer
10/03/2012
ImmunoCellular Therapeutics to Present at 3 rd Annual Cancer Immunotherapy Conference and 2012 BIO Investor Forum
Cell Therapeutics` brain cancer drug gets orphan status
09/29/2012
Model T muscle CARs can treat brain tumors.
09/22/2012
The impact of enrollment in clinical trials on survival of patients with glioblastoma.
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
09/19/2012
Moving Medicine Forward: Breakthroughs in Research
Marijuana And Cancer: Scientists Find Cannabis Compound Stops Metastasis In Aggressive Cancers
IBTA Newsletter
Coated nanoparticles move easily into brain tissue
09/16/2012
Gross Total Resection Rates in Contemporary Glioblastoma Surgery: Results of an Institutional Protocol Combining 5-ALA Intraoperative Fluorescence Imaging and Brain Mapping.
The American Brain Foundation is now accepting video entries to its 2013 Neuro Film Festival.
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Ra2 tumor-restricted biomarker.
The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.